Immix Biopharma (IMMX) Shares Issued (2023 - 2025)

Immix Biopharma has reported Shares Issued for 7 years, with the latest figure at $5.3 million in Q1 2026.

• Quarterly Shares Issued rose 30.44% year-over-year to $5.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.3 million (up 30.44% YoY) and the FY2025 annual result came in at $5.3 million, up 29.47% from the prior year.
• Shares Issued rose to $5.3 million in Q1 2026 per IMMX's latest filing, from $5.3 million in the prior quarter.
• Over five years, Shares Issued peaked at $5.3 million in Q1 2026 and troughed at $1.2 million in Q2 2022.
• A 5-year average of $3.2 million and a median of $2.5 million in 2023 frame the typical range for Shares Issued.
• The sharpest annual moves came in 2022 and 2024: Shares Issued advanced 0.57% in 2022, then jumped 125.83% in 2024.
• Over 5 years, Shares Issued stood at $1.8 million in 2022, then surged by 41.85% to $2.5 million in 2023, then jumped by 61.83% to $4.1 million in 2024, then gained by 29.47% to $5.3 million in 2025, then increased by 1.37% to $5.3 million in 2026.
• According to Business Quant data, Shares Issued over the past three periods registered $5.3 million, $5.3 million, and $4.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.